Evidence map›Paper›PMID 39039523›Full record

ArticleOrphanet journal of rare diseases2024

Novel approach for tracheal resection in Morquio a syndrome with end-stage critical airway obstruction: a UK case series.

Johnny Kenth, Elizabeth Maughan, Colin R Butler, Jasleen Gabrie, Maral Rouhani, Benjamin Silver, Olumide K Ogunbiyi, Stuart Wilkinson, Reema Nandi, Robert Walker and 4 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Natural History of Morquio A Syndrome.Journal of inherited metabolic disease · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Johnny KenthDepartment of Paediatric Anaesthesia, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK. jkenth@me.com.ORCID 0000-0002-0348-6865
Elizabeth MaughanNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Colin R ButlerNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Jasleen GabrieNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Maral RouhaniNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Benjamin SilverNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Olumide K OgunbiyiGreat Ormond Street Hospital for Children, NHS Foundation Trust Research Histopathology Service, London, UK.
Stuart WilkinsonDepartment of Paediatric Respiratory Medicine, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Reema NandiNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Robert WalkerDepartment of Paediatric Anaesthesia, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Nagarajan MuthialuNational Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Simon JonesDivisions of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Richard Hewitt *National Paediatric Tracheal Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Iain A Bruce *Divisions of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Funding

National MPS Society (UK) CSAC-KEN.MFT.202105NIHR Doctoral Fellowship NIHR302309
6 · The paper itself

Abstract

backgroundMucopolysaccharidosis (MPS) type IVA is a rare lysosomal storage disorder caused by aberrations of the N-acetyl-galactosamine-6-sulfatase (GALNS) enzyme. MPS IVA is associated with a wide gamut of respiratory and airway disorders that manifest in a continuum of severity. In individuals exhibiting severe phenotypic expression, terminal stages of the disease frequently culminate in life-threatening, critical airway obstruction. These manifestations of end-stage disease are engendered by an insidious progression of multi-level airway pathologies, comprising of tracheomalacia, stenosis, tortuosity and 'buckling'. Historically, the management of end-stage airway disease has predominantly leaned towards palliative modalities. However, contemporary literature has posited that the potential benefits of tracheal resection with aortopexy, performed under cardiopulmonary bypass (CPB), may offer a promising therapeutic option. In this context, we report on outcomes from patients undergoing a novel approach to tracheal resection that is combined with manubrial resection, leading to improved airway calibre, obviating the requisition for CPB.

resultsIn this study, seven patients with severe MPS IVA exhibited clinical symptoms and radiological evidence indicative of advanced airway obstruction. All patients had a tracheal resection with a partial upper manubriectomy via transcervical approach, which did not require CPB. The surgical cohort consisted of 5 females and 2 males, the median age was 16 years (range 11-19) and the median height was 105.6cm (range 96.4-113.4). Postoperatively, significant improvements were seen in forced expiratory volume in 1 second (FEV1), with a mean increase of 0.68 litres (95% CI: 0.45-0.91; SD: 0.20). Notably, other spirometry variables also showed meaningful improvements, providing evidence of positive treatment effects. Furthermore, there were no major long-term complications, and the procedure resulted in a significant enhancement in patient-reported domains using PedsQL (version 4.0).

conclusionsThis study represents the largest case series to date, on tracheal resection in patients with severe MPS IVA. Our findings demonstrate the effectiveness of the transcervical approach with partial manubriectomy for improving respiratory function and quality of life for individuals with advanced airway obstruction. Tracheal resection presents a promising treatment modality for severe cases of MPS IVA. Successful outcomes rely on meticulous multidisciplinary assessment, judicious decision-making, and appropriate timing of tracheal surgery. Further research and long-term follow-up studies are warranted to validate the long-term efficacy and safety of this approach.

Indexed as

Airway ObstructionMucopolysaccharidosis IVTracheaAdolescentAdultChildFemaleHumansMaleUnited KingdomYoung Adult

Identifiers

PMID39039523
PMCPMC11264958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.